chitosan has been researched along with diminazene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AA; Fernandes, SO; Ferreira, AJ; Foureaux, G; Franca, JR; Fulgêncio, Gde O; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
| Castilho, RO; Cesar, ALA; Cronemberger, S; Ferreira, AJ; Foureaux, G; Gomes Faraco, AA; Goulart, GAC; Navarro, LC | 1 |
2 other study(ies) available for chitosan and diminazene
| Article | Year |
|---|---|
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Topics: Administration, Ophthalmic; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Diminazene; Drug Evaluation, Preclinical; Enzyme Activation; Eye Proteins; Glaucoma; Hyaluronic Acid; Intraocular Pressure; Male; Microscopy, Electron, Scanning; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |
New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study.
Topics: Animals; Antiglaucoma Agents; Chitosan; Chondroitin Sulfates; Delayed-Action Preparations; Diminazene; Drug Liberation; Glaucoma, Open-Angle; Male; Rats; Rats, Wistar | 2021 |